InvestorsHub Logo
Followers 15
Posts 309
Boards Moderated 0
Alias Born 09/13/2019

Re: C-20 post# 170993

Friday, 06/18/2021 6:04:54 PM

Friday, June 18, 2021 6:04:54 PM

Post# of 233052
You mean "any chance of succeeding" as in U.S. Treatment of Acute COVID right? Because with our Brazil trial design of IV Dosing for 4 weeks we have significant potential of success, along with 1:1 trial arms and larger "N" of 306.

But yes, it is sad that trial design was so awful. The fact that the drug proved successful but because of the trial design we failed, makes me more bitter I would say.

Hoping for some success in Longhauler Trial, but once again we have too small of a trial size, making it infinitely more difficult to obtain proper signals for a P3 LH

2 Fingers for CytoDyn SP and 1 Finger for Rosenbaum

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News